Fusion Pharmaceuticals Inc (NAS:FUSN)
$ 21.55 0 (0%) Market Cap: 1.83 Bil Enterprise Value: 1.69 Bil PE Ratio: 0 PB Ratio: 7.56 GF Score: 38/100

Fusion Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 08:00PM GMT
Release Date Price: $5.19 (-2.63%)
Andrew Tsai
Jefferies - Analyst

Okay, we're going to get started on the next session. I'm Andrew Tsai -- hi, everyone -- senior biotech analyst here at Jefferies. And I'm joined by John Valliant, CEO of Fusion.

Welcome, John.

John Valliant
Fusion Pharmaceuticals Inc. - CEO

Thank you.

Questions & Answers

Andrew Tsai
Jefferies - Analyst

And I think we have 25 minutes for our fireside chat. So, John, to start -- maybe to begin, maybe give us a brief overview of Fusion and -- what is your differentiation versus some of the players out there, in your view? What can you do that others cannot? And then maybe talk about your news flow over the next six to 12 months.

John Valliant
Fusion Pharmaceuticals Inc. - CEO

Sure, Andrew. Happy to. Thanks for everyone joining.

So Fusion is focused on creating next-generation radiopharmaceuticals and, more specifically, targeted alpha therapies. So the general premise of the technology is to connect an alpha

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot